21hon MSN
Krishna Guha, Evercore ISI vice chairman, joins CNBC's 'Squawk Box' to discuss expectations for PPI, how a new Trump ...
Evercore ISI analyst Liisa Bayko maintained a Buy rating on Innate Pharma (IPHA – Research Report) today and set a price target of $5.00.
NEW YORK (Reuters) - Evercore ISI on Wednesday forecast the S&P 500 will rise to 6,600 by mid-2025, saying a "decisive and ...
Capri and Tapestry have mutually agreed to terminate their planned merger. Capri CEO continues to see long-term potential in ...
In a report released today, Mark Mahaney from Evercore ISI maintained a Buy rating on Ibotta, Inc. Class A (IBTA – Research Report), with ...
Artisan Partners Asset Management (NYSE:APAM – Free Report) had its target price boosted by Evercore ISI from $40.00 to $44.00 in a report published on Thursday,Benzinga reports.They currently ...
On October 23, Evercore ISI raised the price target on the stock to $323 from $300 and kept an Outperform rating on the ...
Evercore ISI revised its ratings for several industrial and machinery stocks following the US election results, citing a more optimistic business outlook tied to the anticipated "pro-business Trump" ...
Evercore ISI has recently reduced Academy Sports and Outdoors Inc (ASO) stock rating, as announced on October 3, 2024, according to Finviz. Earlier, on August 13, 2024, TD Cowen had reduced the stock ...
Evercore ISI reiterated an Outperform rating and $22 price target on Bloom Energy (BE) after American Electric Power (AEP) said it has an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback